Novagold Resources Inc. vs Health Care Select Sector SPDR Fund — how do they compare? Novagold Resources Inc. trades at $6.32 (market cap $2.90B), while Health Care Select Sector SPDR Fund trades at $175.45 (market cap $44.49B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 15.3× Novagold Resources Inc.'s market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Novagold Resources Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Novagold Resources Inc. for 0 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| NG | XLV | |
|---|---|---|
Market Cap | $2.90B | $44.49B |
Volume | 3,973,464 | 8,745,019 |
Sector | Basic Materials | — |
52-Week High | $14.20 | $175.68 |
52-Week Low | $5.18 | $142.33 |
Typical Hold Time | 0 Days | 100 Days |
Enterprise Value | $2.74B | — |
Signals from Pluang's Aura AI — not financial advice
NovaGold Resources (NG) trades at $6.63, down 1.49% today, as the company navigates its development phase for the Donlin Gold project. The stock shows mixed earnings performance with recent quarterly losses but beats expectations in two of the last four quarters. Financials reveal negative profitability metrics with ROE at -32.81% and net income of -$94.66M for 2025, though cash flow remains positive due to financing activities. Recent news highlights the company's move to acquire full ownership of Donlin Gold, a major Alaska gold project.
The outlook for NG hinges on successful development of Donlin Gold, with 100% analyst buy ratings signaling strong Wall Street confidence. However, significant execution risks exist given negative earnings and substantial capital requirements. Investors face volatility from gold price fluctuations and project development timelines, making this suitable for those with high risk tolerance seeking exposure to a major gold development story.
XLV trades at $169.66, down 1.35% on the day, while maintaining a bullish technical outlook with strong moving average support. The healthcare ETF's low 0.08% expense ratio and diversified exposure to 60 S&P 500 healthcare stocks provide cost-effective sector access. Recent news highlights XLV's defensive characteristics during potential Fed rate hikes and its competitive positioning against peer healthcare ETFs.
The ETF offers defensive growth exposure with healthcare sector stability, though elevated RSI levels suggest near-term consolidation. Political volatility and pharmaceutical trial failures present sector-specific risks, while XLV's technical strength and institutional interest support continued upside potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NovaGold Resources Inc. is a mineral exploration and development company that holds a majority interest in the Donlin Gold project, an undeveloped gold deposit in Alaska.
Read more on NG →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →